Workflow
丽珠医药：截至7月末回购共计1159.66万股A股
Zhi Tong Cai Jing·2025-08-01 10:57

Group 1 - The company, Lijun Pharmaceutical (01513), announced a share buyback program, having repurchased a total of 11.5966 million A-shares, which represents 1.28% of the company's total share capital [1] - The highest purchase price for the shares was RMB 41.99 per share, while the lowest was RMB 33.21 per share [1] - The total funds used for the buyback amounted to RMB 418 million, excluding transaction costs [1]